CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C10704 | BRD-K26233379 | BRD-K26233379 | -- | -- | -- | Details |
C10705 | BRD-K26233698 | BRD-K26233698 | -- | -- | -- | Details |
C10706 | BRD-K26237438 | BRD-K26237438 | -- | -- | -- | Details |
C10707 | BRD-K26241953 | piceatannol | -- | -- | -- | Details |
C10708 | BRD-K26245595 | BRD-K26245595 | -- | -- | -- | Details |
C10709 | BRD-K26251149 | BRD-K26251149 | -- | -- | -- | Details |
C10710 | BRD-K26252750 | BRD-K26252750 | -- | -- | -- | Details |
C10711 | BRD-K26257310 | BRD-K26257310 | -- | -- | -- | Details |
C10712 | BRD-K26257340 | BRD-K26257340 | -- | -- | -- | Details |
C10713 | BRD-K26258603 | BRD-K26258603 | -- | -- | -- | Details |
C10714 | BRD-K26263099 | BRD-K26263099 | -- | -- | -- | Details |
C10715 | BRD-K26263816 | o-nitrosotoluene | -- | -- | -- | Details |
C10716 | BRD-K26272845 | BRD-K26272845 | -- | -- | -- | Details |
C10717 | BRD-K26273412 | BRD-K26273412 | -- | -- | -- | Details |
C10718 | BRD-K26273696 | BRD-K26273696 | -- | -- | -- | Details |
C10719 | BRD-K26277326 | BRD-K26277326 | -- | -- | -- | Details |
C10720 | BRD-K26282994 | BRD-K26282994 | -- | -- | -- | Details |
C10721 | BRD-K26291134 | BRD-K26291134 | -- | -- | -- | Details |
C10722 | BRD-K26292987 | BRD-K26292987 | -- | -- | -- | Details |
C10723 | BRD-K26298689 | BRD-K26298689 | -- | -- | -- | Details |
C10724 | BRD-K26300881 | KU-C103867 | -- | -- | -- | Details |
C10725 | BRD-K26301430 | BRD-K26301430 | -- | -- | -- | Details |
C10726 | BRD-K26304855 | BRD-K26304855 | -- | -- | -- | Details |
C10727 | BRD-K26306512 | BRD-K26306512 | -- | -- | -- | Details |
C10728 | BRD-K26309991 | BRD-K26309991 | -- | -- | -- | Details |
C10729 | BRD-K26314798 | BRD-K26314798 | -- | -- | -- | Details |
C10730 | BRD-K26319806 | BRD-K26319806 | -- | -- | -- | Details |
C10731 | BRD-K26321439 | BRD-K26321439 | -- | -- | -- | Details |
C10732 | BRD-K26325692 | API-001 | SIGMAR1 | Sigma receptor antagonist | -- | Details |
C10733 | BRD-K26327304 | BRD-K26327304 | -- | -- | -- | Details |
C10734 | BRD-K26335565 | BRD-K26335565 | -- | -- | -- | Details |
C10735 | BRD-K26341917 | L-ergothioneine | -- | -- | l-ergothioneine | Details |
C10736 | BRD-K26347562 | BRD-K26347562 | -- | -- | -- | Details |
C10737 | BRD-K26349472 | OG-L002 | KDM1A | Histone lysine demethylase inhibitor | -- | Details |
C10738 | BRD-K26350615 | BRD-K26350615 | -- | -- | -- | Details |
C10739 | BRD-K26351062 | BRD-K26351062 | -- | -- | -- | Details |
C10740 | BRD-K26359746 | BRD-K26359746 | -- | -- | -- | Details |
C10741 | BRD-K26361872 | BRD-K26361872 | -- | -- | -- | Details |
C10742 | BRD-K26362026 | BRD-K26362026 | -- | -- | -- | Details |
C10743 | BRD-K26367064 | BRD-K26367064 | -- | -- | -- | Details |
C10744 | BRD-K26370510 | BRD-K26370510 | -- | -- | -- | Details |
C10745 | BRD-K26373640 | BRD-K26373640 | -- | -- | IKK-2-inhibitor | Details |
C10746 | BRD-K26373865 | BRD-K26373865 | -- | -- | -- | Details |
C10747 | BRD-K26376097 | BRD-K26376097 | -- | -- | -- | Details |
C10748 | BRD-K26381032 | BRD-K26381032 | -- | -- | -- | Details |
C10749 | BRD-K26383086 | BRD-K26383086 | -- | -- | -- | Details |
C10750 | BRD-K26391060 | BRD-K26391060 | -- | -- | -- | Details |
C10751 | BRD-K26393435 | BRD-K26393435 | -- | -- | -- | Details |
C10752 | BRD-K26395018 | BRD-K26395018 | -- | -- | -- | Details |
C10753 | BRD-K26399147 | BRD-K26399147 | -- | -- | -- | Details |
C10754 | BRD-K26399271 | BRD-K26399271 | -- | -- | -- | Details |
C10755 | BRD-K26402831 | BRD-K26402831 | -- | -- | -- | Details |
C10756 | BRD-K26421164 | BRD-K26421164 | -- | -- | -- | Details |
C10757 | BRD-K26423054 | BRD-K26423054 | -- | -- | -- | Details |
C10758 | BRD-K26425257 | BRD-K26425257 | -- | -- | -- | Details |
C10759 | BRD-K26427778 | BRD-K26427778 | -- | -- | -- | Details |
C10760 | BRD-K26429091 | J-104129 | CHRM3 | Acetylcholine receptor antagonist | -- | Details |
C10761 | BRD-K26431593 | BRD-K26431593 | -- | -- | -- | Details |
C10762 | BRD-K26435104 | BRD-K26435104 | -- | -- | -- | Details |
C10763 | BRD-K26441788 | BRD-K26441788 | -- | -- | -- | Details |
C10764 | BRD-K26443253 | BRD-K26443253 | -- | -- | -- | Details |
C10765 | BRD-K26449125 | BRD-K26449125 | -- | -- | -- | Details |
C10766 | BRD-K26453528 | BRD-K26453528 | -- | -- | -- | Details |
C10767 | BRD-K26457096 | BRD-K26457096 | -- | -- | -- | Details |
C10768 | BRD-K26459891 | BRD-K26459891 | -- | -- | -- | Details |
C10769 | BRD-K26461874 | BRD-K26461874 | -- | -- | -- | Details |
C10770 | BRD-K26461918 | BRD-K26461918 | -- | -- | -- | Details |
C10771 | BRD-K26472648 | BRD-K26472648 | -- | -- | -- | Details |
C10772 | BRD-K26479796 | BRD-K26479796 | -- | -- | -- | Details |
C10773 | BRD-K26481999 | BRD-K26481999 | -- | -- | -- | Details |
C10774 | BRD-K26484639 | BRD-K26484639 | -- | -- | -- | Details |
C10775 | BRD-K26484692 | BRD-K26484692 | -- | -- | -- | Details |
C10776 | BRD-K26499328 | BRD-K26499328 | -- | -- | -- | Details |
C10777 | BRD-K26503698 | BRD-K26503698 | -- | -- | -- | Details |
C10778 | BRD-K26507936 | BRD-K26507936 | -- | -- | -- | Details |
C10779 | BRD-K26508045 | BRD-K26508045 | -- | -- | -- | Details |
C10780 | BRD-K26508889 | BRD-K26508889 | -- | -- | -- | Details |
C10781 | BRD-K26510616 | BRD-K26510616 | -- | -- | -- | Details |
C10782 | BRD-K26511533 | BRD-K26511533 | -- | -- | -- | Details |
C10783 | BRD-K26521938 | dinoprostone | PTGER1; PTGER2; PTGER3; PTGER4 | Prostanoid receptor agonist | -- | Details |
C10784 | BRD-K26522558 | BRD-K26522558 | -- | -- | -- | Details |
C10785 | BRD-K26526202 | BRD-K26526202 | -- | -- | -- | Details |
C10786 | BRD-K26531771 | EPZ-5676 | DOT1L | DOT1L inhibitor | -- | Details |
C10787 | BRD-K26537262 | BRD-K26537262 | -- | -- | -- | Details |
C10788 | BRD-K26542939 | BRD-K26542939 | -- | -- | -- | Details |
C10789 | BRD-K26543702 | BRD-K26543702 | -- | -- | -- | Details |
C10790 | BRD-K26545050 | BRD-K26545050 | -- | -- | -- | Details |
C10791 | BRD-K26545157 | BRD-K26545157 | -- | -- | -- | Details |
C10792 | BRD-K26548821 | BRD-K26548821 | -- | -- | quinpirol-(-) | Details |
C10793 | BRD-K26552461 | BRD-K26552461 | -- | -- | -- | Details |
C10794 | BRD-K26553253 | BRD-K26553253 | -- | -- | -- | Details |
C10795 | BRD-K26555669 | BRD-K26555669 | -- | -- | -- | Details |
C10796 | BRD-K26559753 | BRD-K26559753 | -- | -- | -- | Details |
C10797 | BRD-K26569518 | BRD-K26569518 | -- | -- | -- | Details |
C10798 | BRD-K26570871 | BRD-K26570871 | -- | -- | -- | Details |
C10799 | BRD-K26573499 | DMAB-anabaseine | CHRNA7 | Adrenergic receptor agonist | dmab-anabaseine | Details |
C10800 | BRD-K26576471 | BRD-K26576471 | -- | -- | -- | Details |
C10801 | BRD-K26581628 | BRD-K26581628 | -- | -- | -- | Details |
C10802 | BRD-K26582498 | BRD-K26582498 | -- | -- | -- | Details |
C10803 | BRD-K26583430 | BRD-K26583430 | -- | -- | -- | Details |